Picard Medical (PMI) Net Equity Issued and Repurchased (2025)

Picard Medical (PMI) posted Net Equity Issued and Repurchased of $13.7 million for Q3 2025, up 1293.3% on a QoQ basis from $985000.0 in Q2 2025.

Picard Medical (PMI) Net Equity Issued and Repurchased (2025) Analysis & Trends

Picard Medical's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $13.7 million for Q3 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $13.7 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $14.7 million (changed N/A YoY) and the FY2025 annual result came in at $15.2 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $13.7 million for Q3 2025 at Picard Medical, up from $985000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $13.7 million in Q3 2025 and bottomed at $500000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Picard Medical 6.70 Mn 6.70 Mn 275,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 13.72 Mn
Sep 30, 2025 13.72 Mn
Jun 30, 2025 985,000.00
Jun 30, 2025 985,000.00
Mar 31, 2025 500,000.00
Mar 31, 2025 500,000.00